Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Enterprise Value: 2013-2025

Historic Enterprise Value for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $1.6 billion.

  • Phibro Animal Health's Enterprise Value rose 89.07% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 159.51%. This contributed to the annual value of $958.2 million for FY2025, which is 69.70% up from last year.
  • Phibro Animal Health's Enterprise Value amounted to $1.6 billion in Q3 2025, which was up 62.26% from $958.2 million recorded in Q2 2025.
  • Phibro Animal Health's Enterprise Value's 5-year high stood at $1.6 billion during Q3 2025, with a 5-year trough of $376.5 million in Q4 2023.
  • Moreover, its 3-year median value for Enterprise Value was $564.6 million (2024), whereas its average is $707.1 million.
  • In the last 5 years, Phibro Animal Health's Enterprise Value plummeted by 41.70% in 2022 and then spiked by 122.82% in 2024.
  • Over the past 5 years, Phibro Animal Health's Enterprise Value (Quarterly) stood at $731.6 million in 2021, then plummeted by 36.48% to $464.7 million in 2022, then fell by 18.98% to $376.5 million in 2023, then surged by 122.82% to $839.0 million in 2024, then soared by 89.07% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $958.2 million for Q2 2025, and $794.8 million during Q1 2025.